Pfizer Global Manufacturing is restructuring its worldwide plant network in an effort to align its manufacturing and supply organization following the acquisition of Wyeth. The first phase includes shutting down operations at eight manufacturing sites in Ireland, Puerto Rico, and the U.S. by the end of 2015, with additional plans to reduce operations at six other plants in Germany, Ireland, PR, the UK, and the U.S. As a result, 6,000 jobs will be cut during the next several years. “The restr...